Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
gut microbiota1104 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11827 | 30719448 | Biomed Res Int | Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11857 | 30706694 | J Dig Dis | Role of gut microbial metabolites in nonalcoholic fatty liver disease. | 2019 | Details |
| A11895 | 30690636 | Poult Sci | Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model. | 2019 | Details |
| A11912 | 30683985 | Cell Mol Life Sci | The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11922 | 30680920 | Mol Nutr Food Res | Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. | 2019 | Details |
| A11946 | 30671174 | Oxid Med Cell Longev | Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A11947 | 30671129 | Evid Based Complement Alternat Med | Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota. | 2018 | Details |
| A11951 | 30670819 | Nat Rev Endocrinol | Gut microbial metabolites in obesity, NAFLD and T2DM. | 2019 | Details |
| A11974 | 30660825 | Pharmacol Res | Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites. | 2019 | Details |
| A11983 | 30658519 | Int J Mol Sci | Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. | 2019 | Details |
| A11985 | 30658440 | Int J Mol Sci | Interactions between Host PPARs and Gut Microbiota in Health and Disease. | 2019 | Details |
| A11986 | 30658094 | Pharmacol Res | Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. | 2019 | Details |
| A11992 | 30654392 | Semin Liver Dis | NASH in Lean Individuals. | 2019 | Details |
| A12002 | 30652107 | Microb Cell | Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD. | 2018 | Details |
| A12008 | 30647436 | Eur J Clin Nutr | A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. | 2019 | Details |
| A12010 | 30646522 | Int J Mol Sci | Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis. | 2019 | Details |
| A12017 | 30642098 | Microorganisms | Microbial Fermentation of Dietary Protein: An Important Factor in Diet⁻Microbe⁻Host Interaction. | 2019 | Details |
| A12040 | 30628563 | Proc Nutr Soc | Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis. | 2019 | Details |
| A12063 | 30618733 | Front Pharmacol | Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet. | 2018 | Details |
| A12068 | 30616887 | Biochem Biophys Res Commun | Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice. | 2019 | Details |
| A12093 | 30605818 | Environ Pollut | Effects of triphenyl phosphate exposure during fetal development on obesity and metabolic dysfunctions in adult mice: Impaired lipid metabolism and intestinal dysbiosis. | 2018 | Details |
| A12114 | 30596786 | PLoS One | Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. | 2018 | Details |
| A12117 | 32864300 | Curr Pharmacol Rep | Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health. | 2019 | Details |
| A12126 | 30591521 | EMBO Mol Med | The role of the microbiome in NAFLD and NASH. | 2019 | Details |
| A12133 | 30589487 | Obes Rev | Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. | 2018 | Details |
| A12151 | 30580671 | Lab Anim | The role of gut microbiota in intestinal and liver diseases. | 2018 | Details |
| A12159 | 30578461 | Adv Exp Med Biol | Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT). | 2019 | Details |
| A12204 | 30563142 | Molecules | Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. | 2018 | Details |
| A12228 | 30555521 | Nutr Metab (Lond) | Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. | 2018 | Details |
| A12262 | 30525304 | Mol Nutr Food Res | SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. | 2018 | Details |
| A12291 | 30527903 | Hepatobiliary Pancreat Dis Int | Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. | 2018 | Details |
| A12293 | 30526624 | J Transl Med | L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. | 2018 | Details |
| A12294 | 30522122 | Cell Physiol Biochem | Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression. | 2018 | Details |
| A12300 | 30519965 | Acta Diabetol | A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? | 2018 | Details |
| A12305 | 30507741 | Transplantation | Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. | 2019 | Details |
| A12336 | 30509561 | J Formos Med Assoc | Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. | 2018 | Details |
| A12373 | 30482910 | Nat Rev Gastroenterol Hepatol | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2019 | Details |
| A12404 | 30469339 | Nutrients | Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD. | 2018 | Details |
| A12405 | 30469030 | Redox Biol | Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. | 2018 | Details |
| A12469 | 30443932 | J Cell Biochem | Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. | 2018 | Details |
| A12503 | 30416839 | Liver Res | Gut microbiota, fatty liver disease, and hepatocellular carcinoma. | 2018 | Details |
| A12515 | 30412872 | Sci Total Environ | Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease. | 2018 | Details |
| A12533 | 30405551 | Front Microbiol | Endotoxemia by Porphyromonas gingivalis Injection Aggravates Non-alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice. | 2018 | Details |
| A12558 | 30392013 | J Gastroenterol | Antimicrobial proteins: intestinal guards to protect against liver disease. | 2018 | Details |
| A12583 | 30377993 | J Microbiol | Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. | 2018 | Details |
| A12604 | 30367045 | Nat Commun | The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. | 2018 | Details |
| A12609 | 30365236 | Hepatol Res | Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis. | 2018 | Details |
| A12707 | 30319417 | Front Pharmacol | The Role of Gut Microbiota in Atherosclerosis and Hypertension. | 2018 | Details |
| A12733 | 30312513 | Liver Int | Potential mechanisms linking gut microbiota and portal hypertension. | 2018 | Details |
| A12760 | 30298840 | Nihon Yakurigaku Zasshi | [Gut microbiota and nonalcoholic steatohepatitis]. | 2018 | Details |
| A12768 | 30297615 | Nutrients | Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics. | 2018 | Details |
| A12778 | 30292107 | J Nutr Biochem | Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. | 2018 | Details |
| A12849 | 30257633 | Med J Aust | The gut microbiota: cause and cure of gut diseases. | 2018 | Details |
| A12928 | 30221912 | Minerva Med | Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study. | 2018 | Details |
| A12975 | 30200724 | Zhongguo Zhong Yao Za Zhi | [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. | 2018 | Details |
| A13012 | 30181611 | Nat Rev Gastroenterol Hepatol | Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer. | 2018 | Details |
| A13021 | 30178233 | Front Med | Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. | 2018 | Details |
| A13024 | 30175608 | Orv Hetil | [The role of gut microbiota in chronic liver diseases, and treatment possibilities]. | 2018 | Details |
| A13029 | 30173562 | Expert Opin Biol Ther | Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. | 2018 | Details |
| A13145 | 30116360 | Exp Ther Med | 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease. | 2018 | Details |
| A13181 | 30098126 | Diabetes Obes Metab | The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. | 2018 | Details |
| A13188 | 30094487 | Curr Atheroscler Rep | Nuts and Cardiovascular Disease Prevention. | 2018 | Details |
| A13215 | 30079055 | Front Microbiol | Genetically Obese Human Gut Microbiota Induces Liver Steatosis in Germ-Free Mice Fed on Normal Diet. | 2018 | Details |
| A13283 | 30051965 | Mol Nutr Food Res | Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet. | 2018 | Details |
| A13285 | 30051518 | Phytother Res | Effect of virgin avocado oil on diet-induced hypercholesterolemia in rats via 1 H NMR-based metabolomics approach. | 2018 | Details |
| A13315 | 30036479 | Mol Pharm | Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. | 2018 | Details |
| A13393 | 30002342 | Nutrients | Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications. | 2018 | Details |
| A13420 | 29987933 | J Agric Food Chem | Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin. | 2018 | Details |
| A13473 | 29956210 | Adv Exp Med Biol | Microbiota, Obesity and NAFLD. | 2018 | Details |
| A13474 | 29956209 | Adv Exp Med Biol | The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A13495 | 29948900 | Sci China Life Sci | Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. | 2018 | Details |
| A13523 | 29931613 | Curr Diab Rep | The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. | 2018 | Details |
| A13526 | 29930468 | World J Gastroenterol | Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. | 2018 | Details |
| A13534 | 29926176 | Eur J Nutr | Lack of liver steatosis in germ-free mice following hypercaloric diets. | 2018 | Details |
| A13596 | 29889226 | Inflamm Bowel Dis | Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography. | 2019 | Details |
| A13710 | 29797516 | Eur J Clin Invest | Exercising the hepatobiliary-gut axis. The impact of physical activity performance. | 2018 | Details |
| A13717 | 29793999 | Diabetes | The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. | 2018 | Details |
| A13728 | 29787859 | Contemp Clin Trials | Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease. | 2018 | Details |
| A13744 | 29779170 | Eur J Nutr | Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. | 2018 | Details |
| A13884 | 29710519 | Biomed Pharmacother | Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. | 2018 | Details |
| A13933 | 29682571 | Biomed Res Int | The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais. | 2018 | Details |
| A13948 | 29675053 | Evid Based Complement Alternat Med | The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota. | 2018 | Details |
| A13969 | 29665135 | Hepatology | Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13973 | 29662454 | Front Physiol | The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis. | 2018 | Details |
| A13976 | 29661926 | Clin Sci (Lond) | Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders. | 2018 | Details |
| A13994 | 29653359 | J Nutr Biochem | The role of the gut microbiota in the pathology and prevention of liver disease. | 2018 | Details |
| A14034 | 29623674 | J Gastrointest Surg | Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. | 2018 | Details |
| A14043 | 29619530 | Diabetologia | Can targeting ANGPTL proteins improve glucose tolerance? | 2018 | Details |
| A14149 | 29563854 | Mediators Inflamm | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14162 | 29557414 | J Gastrointestin Liver Dis | A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial. | 2018 | Details |
| A14190 | 29538359 | Pediatr Res | Gut microbiota in adolescents and the association with fatty liver: the EPOCH study. | 2018 | Details |
| A14199 | 29531278 | Sci Rep | Author Correction: Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. | 2018 | Details |
| A14241 | 29508520 | Mol Nutr Food Res | Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats. | 2018 | Details |
| A14286 | 29482963 | Nutr Metab Cardiovasc Dis | Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. | 2017 | Details |
| A14343 | 29456073 | Cell Metab | An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. | 2018 | Details |
| A14366 | 29445363 | Front Microbiol | Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. | 2018 | Details |
| A14424 | 29413959 | Redox Biol | Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. | 2018 | Details |
| A14458 | 29401710 | Nutrients | Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14485 | 29389988 | PLoS One | Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis. | 2018 | Details |
| A14502 | 29379536 | Arch Med Sci | Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? | 2016 | Details |